BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30607119)

  • 1. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
    Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
    Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
    Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
    Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
    Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
    Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.
    Russo M; Liu K; Chan C
    Reprod Biol Endocrinol; 2020 Jun; 18(1):59. PubMed ID: 32503566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
    Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
    JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
    Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
    J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oocyte cryopreservation for women with GATA2 deficiency.
    Zolton JR; Parikh TP; Hickstein DD; Holland SM; Hill MJ; DeCherney AH; Wolff EF
    J Assist Reprod Genet; 2018 Jul; 35(7):1201-1207. PubMed ID: 29532200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random-start ovarian stimulation in patients with cancer.
    Cakmak H; Rosen MP
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
    Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
    J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
    Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
    J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
    Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
    Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.